
JSR Micro, Inc. | Materials Innovation
JSR Micro Inc. Materials Innovation, Europe, Asia and US, the global network partner is based in Tokyo
JSR Micro
JSR Micro NV, based in Leuven, Belgium, is a subsidiary of JSR Corporation, a multinational company employing over 8000 people worldwide and a leading materials supplier in a variety of technology …
JSR Micro, Inc. - LinkedIn
JSR Micro, Inc. is the US-based subsidiary of JSR Corporation, which operates a responsive, reliable, world-class supply chain and quality program, and a network of manufacturing facilities,...
About JSR - JSR Micro, Inc.
JSR Micro, Inc. is the US-based subsidiary of JSR Corporation, which operates a responsive, reliable, world-class supply chain and quality program, and a network of manufacturing facilities, sales offices …
JSR North America Holdings | JSR NAHQ
JSR Micro, Inc. is the US-based subsidiary of JSR Corporation, which operates a responsive, reliable, world-class supply chain and quality program, and a network of manufacturing facilities, sales offices …
Careers Chemical Industry | JSR Micro, Inc.
We appreciate and welcome your interest in joining JSR Micro. We are seeking job candidates who display intelligence, creative thinking and proven experience in a customer-oriented and results …
Semiconductor - JSR Micro
JSR Micro produces an advanced range of photoresists, hardmasks, and speciality chemicals designed to address every lithographic challenge, from non-critical i-line to complex multi-patterning techniques.
About - JSR Micro
JSR Micro NV, based in Leuven, Belgium, is a subsidiary of JSR Corporation, a multinational company employing over 9000 people worldwide and a leading materials supplier in a variety of technology …
Corporate Profile - JSR Micro, Inc.
JSR Micro, Inc. Established in 1990 Employs more than 200 people Headquartered in Sunnyvale, CA President: Mark Slezak JSR Corporation Established December 10, 1957 Publicly traded on the …
Our products - JSR Micro
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated …